1 minute reading time (74 words)

FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information. This will help ensure that health care professionals discuss the availability of naloxone and assess each patient's need for a naloxone prescription when opioid pain relievers or medicines to treat OUD are being prescribed or renewed. The patient Medication Guides will also be updated. Full story.

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More